Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epicatechin in pre-diabetes
NCT02656212Phase 1Completed
- Sponsor
- Veterans Medical Research Foundation
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in prediabetes comparing (+)-epicatechin 30mg with Placebo (2 arms). Primary endpoints: Blood Pressure at Day 7, Heart Rate at Day 7 and 3 more. Started Sep 2015; status: completed.
02
Drugs
(+)-epicatechin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT02656212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656212.